COMMUNIQUÉS West-GlobeNewswire

-
U.S. Department of Defense to Study Pluristem’s PLX-R18 for the Treatment of Mustard Gas Injuries
19/06/2018 -
Zomedica Provides Product Development Update
19/06/2018 -
U.S. Healthcare Leader Joseph R. Swedish Joins Mesoblast Board
19/06/2018 -
Amphastar Announces Approval for Isoproterenol Hydrochloride Injection, USP
19/06/2018 -
Genetic Technologies Announces Heads of Agreement with Swisstec
19/06/2018 -
Transactions in relation to share buyback program
19/06/2018 -
HealthLynked Corp. Announces Implementation of Healthcare Algorithms to Provide Personalized Healthcare Recommendations to its Members
19/06/2018 -
Novo Nordisk A/S - Share repurchase programme
19/06/2018 -
Speakeasy Looks to Expand into German Market -- CFN Media
19/06/2018 -
C-RAD publishes outcome of Employee Warrant Program 2018/2021
19/06/2018 -
Constitutive meeting of Biohit Oyj’s Board of Directors
19/06/2018 -
Shire plc: Rule 2.9 Announcement
19/06/2018 -
Medibio Receives TGA Approval
19/06/2018 -
Sanofi appoints Jean-Baptiste Chasseloup de Chatillon Executive Vice President, Chief Financial Officer
19/06/2018 -
Sanofi nomme Jean-Baptiste Chasseloup de Chatillon au poste de Vice-Président Exécutif, Directeur financier
19/06/2018 -
Esperite N.V. secures external financing of up to EUR 5 million to support its commercial activity and development of innovative technologies
19/06/2018 -
Sanofi : Sanofi completes its acquisition of Ablynx following the expiration of the Squeeze-out Procedure
19/06/2018 -
Sanofi : Sanofi finalise l'acquisition d'Ablynx à la suite de l'expiration de la procédure d'offre de reprise
19/06/2018 -
SANOFI COMPLETES ITS ACQUITISION OF ABLYNX FOLLOWING THE EXPIRATION OF THE SQUEEZE-OUT PROCEDURE
19/06/2018
Pages